Achilles Tendinopathy (AT)
Conditions
Keywords
AT
Brief summary
The aim of this study will be to determine the clinical effects of rigid tape in patients with chronic MAT. The secondary outcomes will be to evaluate the immediate and short term pain, the height and pain during the vertical jump, the satisfaction of the use of the tape and the global rating of change (GROC) of the intervention. This study will be a double-blinded randomized clinical trial comprising a total sample size of 36 participants with MAT of both genders and aged between 18 and 50 years. Subjects will undergo a screening process by a sports medicine doctor by different diagnostic tests to identify those presenting a diagnosis of painful MAT and then, they will be randomized into either a group performing experimental rigid tape (G1), or a group performing placebo tape (G2). The study will assess the subjects immediate and short-term tendon pain following the tape application during running and vertical jump. Also the tape satisfaction and GROC will be assessed. The rigid tape will be applied in the central portion of the Achilles tendon. Primary and secondary outcomes will be measured at baseline, immediate after the application of the tape and 72 hours after. The GROC will only be assessed at the end of the treatment. All the evaluations will be performed by a blinded physiotherapist. The patient will also be blinded.
Interventions
OTHERRigid Tape
Inelastic rigid tape (Strappal) applied to discharge the Achilles tendon
OTHERPlacebo Control
A pre-tape and a short piece of rigid tape applied without tension.
Sponsors
University of Gran Rosario
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Intervention model description
clinical trial with experimental and placebo groups
Eligibility
Sex/Gender
ALL
Age
18 Years to 50 Years
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of unilateral or bilateral MAT * Achilles pain \> 3 months * Age ranging between 18 to 50 years, both genders * Read and speak Spanish well enough to provide informed consent and follow study instructions. * Pain during running and jumping.
Exclusion criteria
* Any ankle or foot surgery * History of Achilles rupture * Heel pain in the last 3 months * Systemic disorders/diseases * Body mass index \> 30kg/m2 * Self-report of pregnancy * Pain \< 2/100 of average pain on VAS * VISA A score \> 90 points
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change on pain intensity | At baseline, immediately and 72 hours after the intervention | The Visual Analog Scale (VAS) will be used to assess pain intensity during running and jumping. This scale consists of a sequence of numbers from 0 (no pain) to 100 mm (most severe pain). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change on single leg vertical jump | At baseline, immediately and 72 hours after the intervention | This test will assess the height in cm and power of a vertical jump using the My Jump app, validated by Gallardo-Fuentes in 2016. The instructions will be jumping as high as possible with hands on the subject's waist. Participants will perform 3 repetitions in a non-consecutive manner. |
| Change on feeling of comfort of the tape | Immediately and 72 hours after the intervention | The satisfaction of the tape will be assessed by the Likert Scale. This rating scale measures the positive or negative response to the intervention. The format of this scale will be divided into five levels: very uncomfortable, uncomfortable, normal, comfortable, and very comfortable. |
| Change in perception of improvement of the treatment | 72 hours after the intervention | The Global Rating of Change (GROC) scale is a patient-reported outcome measure used to assess the subjective perception of change in a patient's condition following an intervention. It helps determine whether a patient's condition has improved, worsened, or remained the same since the start of treatment. The magnitude of this difference is recorded on an 11-point visual analog scale, starting from 0 (no change) as the midpoint, and presenting at its extremes -5 (much worse) and +5 (completely better). |
Contacts
Primary ContactGonzalo Elías, PT Msc
Outcome results
None listed